Back to Search
JENNY BACKMAN, M.D.
M.D.
Obstetrics Physician
NPI: 1790122471IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics PhysicianPrimary
Obstetrics & Gynecology — Obstetrics
Code: 207VX0000X
18301(NH)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans.
PMID 19387419·Pharmacogenet Genomics·2009
8-other
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.
PMID 19324974·Am J Respir Crit Care Med·2009
4-observational
Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism.
PMID 19238654·Clin Pharmacol Ther·2008
2-rct
Itraconazole, a potent inhibitor of P-glycoprotein, moderately increases plasma concentrations of oral morphine.
PMID 19025521·Acta Anaesthesiol Scand·2008
2-rct
Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone.
PMID 17913794·Drug Metab Dispos·2008
2-rct
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
PMID 18816299·Basic Clin Pharmacol Toxicol·2008
8-other
Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.
PMID 17955229·Eur J Clin Pharmacol·2008
2-rct
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo.
PMID 18388877·Clin Pharmacol Ther·2008
2-rct
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.
PMID 17923851·Pharmacogenomics J·2008
4-observational
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.
PMID 18197403·Eur J Clin Pharmacol·2008
2-rct
Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
PMID 18854776·Pharmacogenet Genomics·2008
3-trial
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
PMID 18563955·Clin Pharmacokinet·2008
6-review
Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms.
PMID 18192894·Pharmacogenet Genomics·2008
8-other
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
PMID 17333159·Eur J Clin Pharmacol·2007
2-rct
Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
PMID 17662086·Br J Clin Pharmacol·2007
4-observational
The early Miocene onset of a ventilated circulation regime in the Arctic Ocean.
PMID 17581581·Nature·2007
8-other
Characterization of adducts formed in the reaction of glutaraldehyde with 2'-deoxyadenosine.
PMID 17518482·Chem Res Toxicol·2007
7-preclinical
Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4.
PMID 17392729·Clin Pharmacol Ther·2007
2-rct
Reaction of glycidamide with 2'-deoxyadenosine and 2'-deoxyguanosine--mechanism for the amide hydrolysis.
PMID 17365793·Nucleosides Nucleotides Nucleic Acids·2007
8-other
Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.
PMID 17618427·Eur J Clin Pharmacol·2007
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 TARRYTOWN RD
MANCHESTER, NH 03103 - Phone
- (603) 622-3162
Quick Facts
- NPI
- 1790122471
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile